What is Repligen's financing cash flow?

Repligen (RGEN) reported financing cash flow of -$5.54M in Q1 2026.

How has Repligen's financing cash flow changed year-over-year?

Repligen's financing cash flow decreased by 10.2% year-over-year, from -$5.03M to -$5.54M.

What is the long-term trend for Repligen's financing cash flow?

Over 3 years (2022 to 2025), Repligen's financing cash flow has grown at a 1.8% compound annual growth rate (CAGR), from -$14.59M to -$15.4M.

What does financing cash flow mean?

Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Repligen RGEN Financing Cash Flow

Financing Cash Flow at other companies

TEC

Bio-TechneTECH

-$42.72M+37.2%

RevvityRVTY

-$88.9M+45.7%

Thermo Fisher ScientificTMO

$1.09B+1,172%

DanaherDHR

$46M+104%

Agilent TechnologiesA

-$144M-24.1%

Bio-Rad LaboratoriesBIO

-$44M+55.0%

Other financials

Income statement

See full

Revenue$194.3M+14.8%

Gross profit$108.3M+18.5%

Operating income$15.9M+142%

Net income$8.3M+42.9%

EPS (diluted)$0.15+50.0%

Balance sheet

See full

Cash & equivalents$582.7M-16.4%

Total debt$687.6M+346%

Total equity$2.1B+6.0%

Total assets$2.9B+2.8%

Cash flow

See full

Operating cash flow$28.3M+88.6%

CapEx$4.7M+32.2%

Free cash flow$23.6M+106%

Valuation

See full

Market cap$7.45B-7.1%

Enterprise value$7.55B+2.1%

P/E144.9×—

P/S10.1×-0.1×

Profitability

See full

Gross margin49.5%+2.7pp

Operating margin1.5%-14.0pp

Net margin17.1%-3.7pp

FCF margin21.2%+6.1pp

Returns & leverage

See full

Return on equity2.5%+1.9pp

Debt / equity0.3×+0.2×

Current ratio9.2×+2.4×

Where this comes from

Reported directly by Repligen in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The official record: Repligen’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Repligen's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Repligen's financing cash flow?: Repligen (RGEN) reported financing cash flow of -$5.54M in Q1 2026.
How has Repligen's financing cash flow changed year-over-year?: Repligen's financing cash flow decreased by 10.2% year-over-year, from -$5.03M to -$5.54M.
What is the long-term trend for Repligen's financing cash flow?: Over 3 years (2022 to 2025), Repligen's financing cash flow has grown at a 1.8% compound annual growth rate (CAGR), from -$14.59M to -$15.4M.
What does financing cash flow mean?: Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.